[Labyrinthine and cerebral blood flow. Effect of vasodilator agents on the cochlear blood circulation].
D000818:Animals; D001921:Brain / Q000098:blood supply; D002245:Carbon Dioxide / Q000494:pharmacology; D002463:Cell Membrane Permeability; D002555:Cerebrospinal Fluid / Q000502:physiology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003051:Cochlea / Q000098:blood supply*; D004395:Dye Dilution Technique; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D007761:Labyrinthine Fluids / Q000502:physiology*; D008722:Methods; D009584:Nitrogen / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D014462:Ultrafiltration; D014665:Vasodilator Agents / Q000494:pharmacology*
D014665:Vasodilator Agents; D002245:Carbon Dioxide; D010208:Papaverine; D009584:Nitrogen; D004837:Epinephrine
Innenohr- und Hirndurchblutung. Uber die Wirkung fefässerweiternder Mittel auf die kochleäre Durchblutung.